Endo Pharmaceuticals Inc.

PA · United States · Reporting entity ID 100000000285

Total reported 2019–2025

$48.0M

#180 of 2,960 reporting companies — 0.1% of all reported industry payments

$10.4M in general payments across 85,870 records, plus $37.7M in research funding across 4,162 records.

How it breaks down

General payments $10,351,347

Research funding $37,694,129

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.